Product News

Share this article:

AstraZeneca's Seroquel XR picked up an indication for the treatment of acute depressive, manic, and mixed episodes of bipolar disorder. The drug is now available in two new tablet strengths: 50 mg and 150 mg.

Takeda's proton pump inhibitor Kapidex received FDA approval for the treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE. It is now available in US pharmacies in 30mg and 60mg doses.

Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.